Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
Psychedelics Investing MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
Pharmaceutical Investing U.S. FDA Accepts for Priority Review the Biologics License Application for V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine, for Use in Adults 18 Years of Age and Older
Pharmaceutical Investing Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
Medical Device Investing Abbott Receives FDA 510 Clearance for the First Rapid Handheld Blood Test for Concussions
Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment
